CCCL [China Ceramics] 6-K: Contact Information: China Ceramics Co., Ltd. Precept Investor

[Contact Information: China Ceramics Co., Ltd. Precept Investor Relations LLC Edmund Hen, Chief Financial Officer David Rudnick, Account Manager Email: info@cceramics.com Email: david.rudnick@preceptir.com Phone: +1 917-864-8849 China Ceramics Announces First Quarter 2016 Financial Results Jinjiang, Fujian Province, China, June 2, 2016 First Quarter 2016 Highlights § Revenue was RMB 134.2 million (US$ 20.8 million), down 36.0% from the first quarter] []

By | 2016-06-04T03:05:59+00:00 June 3rd, 2016|Categories: CCCL, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] SC 13D/A: Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES

[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]

XRS [TAL Education] 20-F/A:

[] [I, Bangxin Zhang, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of TAL Education Group; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [Certification by the Principal Financial Officer I, Rong Luo, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of TAL Education Group; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,]

By | 2016-06-04T02:48:03+00:00 June 3rd, 2016|Categories: Chinese Stocks, Webplus ver, XRS|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] SC 13G/A: CUSIP NO. 67107W 10 0 Page 2 of

[CUSIP NO. 67107W 10 0 Page 2 of 6 1. Name of reporting persons: I.R.S. Identification Nos. of above persons (entities only): DNB Asset Management AS 2. Check the appropriate box if a member of a group: ¨ ¨ (a) 3. SEC use only: 4. Citizenship or place of organization: Kingdom of Norway Number of shares beneficially owned by each]

SEED [Origin Agritech] SC 13D/A: Joint Filing Agreement [ Liang Yuan Liang Yuan

[Joint Filing Agreement [ Liang Yuan Liang Yuan Bonasmart Limited Liang Yuan Director EX-99.1 2 d193821dex991.htm EX-99.1] [13D CUSIP No. G67828106 Page 2 of 7 Pages 1 Names of reporting persons Liang Yuan 2 Check the appropriate box if a member of a group (see instructions) ¨ ¨ (a) 3 SEC use only 4 Source of funds (see instructions) OO 5 ¨ 6 Citizenship or place of organization The Hong Kong Special Administrative Region of the People’s]

By | 2016-06-03T13:10:33+00:00 June 2nd, 2016|Categories: Chinese Stocks, SEED, Webplus ver|Tags: , , , , , |0 Comments

WUBA [58.com] 6-K: 58.com Reports First Quarter 2016 Unaudited Financial Results

[58.com Reports First Quarter 2016 Unaudited Financial Results BEIJING, June 2, 2016 --58.com Inc. (NYSE: WUBA) (“58.com” or the “Company”), China’s largest online market place serving local merchants and consumers, today reported its unaudited financial results for the first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights · Total revenues were US$231.3 million, a 165.6% increase from the] []

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Quarter 2016 Financial Results

[Sinovac Reports Unaudited First Quarter 2016 Financial Results BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights (compared to the first quarter of 2015) • Quarterly sales from continuing operations were $11.0 million, an increase] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v441538_6k.htm FORM 6-K]

By | 2016-06-03T13:21:55+00:00 June 2nd, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar